In millions, except per share items | Feb-28-18 | Feb-28-17 | Feb-29-16 | Feb-28-15 | Feb-28-14 | Feb-28-13 | Feb-29-12 | Feb-28-11 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 |
Gross margin | 100.0% | | | | | | | |
Selling, general and administrative [+] | 2.3 | 2.3 | 3.4 | 3.5 | 3.5 | 2.0 | 0.7 | 0.1 |
General and administrative | 2.3 | 2.3 | 3.4 | 3.5 | 3.5 | 2.0 | 0.7 | 0.1 |
Research and development | 1.3 | 1.0 | 1.4 | 1.3 | 0.8 | 0.5 | 0.9 | 0.2 |
Other operating expenses | -0.5 | -0.2 | -0.3 | 2.5 | 1.2 | -2.5 | -1.6 | -0.6 |
EBITDA [+] | -3.0 | -3.0 | -4.4 | -7.3 | -5.5 | 0.0 | 0.0 | 0.0 |
EBITDA growth | -2.4% | -30.5% | -39.8% | 32.0% | -49657.5% | 1079.7% | 187.5% | -100.4% |
EBITDA margin | -12760.3% | | | | | | | |
Depreciation and amortization | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT [+] | -3.1 | -3.1 | -4.5 | -7.3 | -5.5 | 0.0 | 0.0 | 0.0 |
EBIT growth | -2.6% | -29.8% | -39.0% | 32.6% | | | | -100.0% |
EBIT margin | -13143.3% | | | | | | | |
Non-recurring items [+] | | 0.1 | | 0.0 | | | | |
Loss (gain) on sale of assets | | 0.1 | | 0.0 | | | | |
Interest expense, net [+] | 0.1 | 1.1 | 0.3 | 0.6 | -0.1 | 0.0 | | |
Interest expense | 0.1 | 1.1 | 0.3 | 0.6 | | 0.0 | | |
Interest income | | | | | 0.1 | | | |
Other income (expense), net [+] | 0.0 | 1.4 | 0.1 | -0.1 | 0.0 | 0.0 | | |
Amortization of financing costs and debt discount | | | | | 0.0 | | | |
Realized gain (loss) on investments | | | | 0.1 | | | | |
Litigation settlement | | | 0.0 | | | | | |
Gain (loss) on debt retirement | | -1.4 | | | 0.0 | | | |
Gain (loss) on derivative instruments | -0.5 | -2.4 | -0.3 | 0.1 | | | | |
Other non-operating income | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | | | |
Other | 0.0 | 0.0 | 0.1 | -0.1 | 0.0 | | | |
Pre-tax income | -3.2 | -2.9 | -4.7 | -8.0 | -5.4 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | | |
Net income | -3.3 | -6.2 | -6.0 | -8.2 | -5.4 | -2.5 | -2.4 | 0.0 |
Net margin | -14206.6% | | | | | | | |
|
Basic EPS [+] | ($0.61) | ($2.10) | ($3.30) | ($4.96) | ($0.25) | ($0.12) | ($0.15) | $0.00 |
Growth | -70.9% | -36.4% | -33.5% | 1855.7% | 110.0% | -19.5% | | -100.0% |
Diluted EPS [+] | ($0.61) | ($2.10) | ($3.30) | ($4.96) | ($0.25) | ($0.12) | ($0.15) | $0.00 |
Growth | -70.9% | -36.4% | -33.5% | 1855.7% | 110.0% | -19.5% | | -100.0% |
|
Shares outstanding (basic) [+] | 5.4 | 3.0 | 1.8 | 1.7 | 21.2 | 20.9 | 16.2 | 9.9 |
Growth | 82.9% | 63.3% | 9.3% | -92.1% | 1.4% | 29.0% | 63.9% | 1898.6% |
Shares outstanding (diluted) [+] | 5.4 | 3.0 | 1.8 | 1.7 | 21.2 | 20.9 | 16.2 | 9.9 |
Growth | 82.9% | 63.3% | 9.3% | -92.1% | 1.4% | 29.0% | 63.9% | 1898.6% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |